Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma
(2021) In Oncotarget 11(35). p.4822-4835- Abstract
Gliomas are the most common intracranial primary tumors, for which very few therapeutic options are available. The most malignant subtype is the glioblastoma, a disease associated with a 5-year survival rate lower than 5%. Given that research in glycobiology continues highlighting the role of glycans in tumor cell biology, it offers an interesting niche for the search of new therapeutic targets. In this study, we characterized aberrant glycosylation and its impact on cell biology over a broad panel of high- and low-grade glioma cell lines. Results show high expression of terminal Lewis glycans, mainly SLex, and overexpression of sialyl- and fucosyltransferases involved in their biosynthesis in high-grade glioma cell lines.... (More)
Gliomas are the most common intracranial primary tumors, for which very few therapeutic options are available. The most malignant subtype is the glioblastoma, a disease associated with a 5-year survival rate lower than 5%. Given that research in glycobiology continues highlighting the role of glycans in tumor cell biology, it offers an interesting niche for the search of new therapeutic targets. In this study, we characterized aberrant glycosylation and its impact on cell biology over a broad panel of high- and low-grade glioma cell lines. Results show high expression of terminal Lewis glycans, mainly SLex, and overexpression of sialyl- and fucosyltransferases involved in their biosynthesis in high-grade glioma cell lines. Moreover, we report an association of complex multi-antennary N-glycans presenting β1,6-GlcNAc branches with the high-grade glioma cells, which also overexpressed the gene responsible for these assemblies, MGAT5. In addition, downmodulation of N-glycosylation by treatment with the inhibitors Tunicamycin/Swainsonine or MGAT5 silencing decreased SLex expression, adhesion and migration in high-grade glioma cells. In contrast, no significant changes in these cell capacities were observed in low-grade glioma after treatment with the N-glycosylation inhibitors. Furthermore, inhibition of histone deacetylases by Trichostatin A provoked an increase in the expression of SLex and its biosynthetic related glycosyltransferases in low-grade glioma cells. Our results describe that aggressive glioma cells show high expression of Lewis glycans anchored to complex multi-antennary N-glycans. This glycophenotype plays a key role in malignant cell behavior and is regulated by histone acetylation dependent mechanisms.
(Less)
- author
- Cuello, Hector A. ; Ferreira, Gretel M. ; Gulino, Cynthia A. ; Toledo, Alejandro Gomez LU ; Segatori, Valeria I. and Gabri, Mariano R.
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Glioblastoma, Glioma, Histone acetylation, Lewis glycans, N-glycans
- in
- Oncotarget
- volume
- 11
- issue
- 35
- pages
- 14 pages
- publisher
- Impact Journals
- external identifiers
-
- scopus:85099906066
- ISSN
- 1949-2553
- DOI
- 10.18632/ONCOTARGET.27850
- language
- English
- LU publication?
- yes
- id
- 498506f1-717b-4069-a10b-8aeda4f7770d
- date added to LUP
- 2021-02-08 11:35:55
- date last changed
- 2022-04-27 00:06:36
@article{498506f1-717b-4069-a10b-8aeda4f7770d,
abstract = {{<p>Gliomas are the most common intracranial primary tumors, for which very few therapeutic options are available. The most malignant subtype is the glioblastoma, a disease associated with a 5-year survival rate lower than 5%. Given that research in glycobiology continues highlighting the role of glycans in tumor cell biology, it offers an interesting niche for the search of new therapeutic targets. In this study, we characterized aberrant glycosylation and its impact on cell biology over a broad panel of high- and low-grade glioma cell lines. Results show high expression of terminal Lewis glycans, mainly SLe<sup>x</sup>, and overexpression of sialyl- and fucosyltransferases involved in their biosynthesis in high-grade glioma cell lines. Moreover, we report an association of complex multi-antennary N-glycans presenting β1,6-GlcNAc branches with the high-grade glioma cells, which also overexpressed the gene responsible for these assemblies, MGAT5. In addition, downmodulation of N-glycosylation by treatment with the inhibitors Tunicamycin/Swainsonine or MGAT5 silencing decreased SLe<sup>x</sup> expression, adhesion and migration in high-grade glioma cells. In contrast, no significant changes in these cell capacities were observed in low-grade glioma after treatment with the N-glycosylation inhibitors. Furthermore, inhibition of histone deacetylases by Trichostatin A provoked an increase in the expression of SLex and its biosynthetic related glycosyltransferases in low-grade glioma cells. Our results describe that aggressive glioma cells show high expression of Lewis glycans anchored to complex multi-antennary N-glycans. This glycophenotype plays a key role in malignant cell behavior and is regulated by histone acetylation dependent mechanisms.</p>}},
author = {{Cuello, Hector A. and Ferreira, Gretel M. and Gulino, Cynthia A. and Toledo, Alejandro Gomez and Segatori, Valeria I. and Gabri, Mariano R.}},
issn = {{1949-2553}},
keywords = {{Glioblastoma; Glioma; Histone acetylation; Lewis glycans; N-glycans}},
language = {{eng}},
number = {{35}},
pages = {{4822--4835}},
publisher = {{Impact Journals}},
series = {{Oncotarget}},
title = {{Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma}},
url = {{http://dx.doi.org/10.18632/ONCOTARGET.27850}},
doi = {{10.18632/ONCOTARGET.27850}},
volume = {{11}},
year = {{2021}},
}